Viasus, D.; Abelenda-Alonso, G.; Bolivar-Areiza, J.; Gudiol, C.; Carratalà , J.
Effects of Antibiotic De-Escalation on Outcomes in Severe Community-Acquired Pneumonia: An Inverse Propensity Score-Weighted Analysis. Antibiotics 2025, 14, 716.
https://doi.org/10.3390/antibiotics14070716
AMA Style
Viasus D, Abelenda-Alonso G, Bolivar-Areiza J, Gudiol C, Carratalà J.
Effects of Antibiotic De-Escalation on Outcomes in Severe Community-Acquired Pneumonia: An Inverse Propensity Score-Weighted Analysis. Antibiotics. 2025; 14(7):716.
https://doi.org/10.3390/antibiotics14070716
Chicago/Turabian Style
Viasus, Diego, Gabriela Abelenda-Alonso, Juan Bolivar-Areiza, Carlota Gudiol, and Jordi Carratalà .
2025. "Effects of Antibiotic De-Escalation on Outcomes in Severe Community-Acquired Pneumonia: An Inverse Propensity Score-Weighted Analysis" Antibiotics 14, no. 7: 716.
https://doi.org/10.3390/antibiotics14070716
APA Style
Viasus, D., Abelenda-Alonso, G., Bolivar-Areiza, J., Gudiol, C., & Carratalà , J.
(2025). Effects of Antibiotic De-Escalation on Outcomes in Severe Community-Acquired Pneumonia: An Inverse Propensity Score-Weighted Analysis. Antibiotics, 14(7), 716.
https://doi.org/10.3390/antibiotics14070716